Literature DB >> 19459928

Identification of three in-frame deletion mutations in MYH9 disorders suggesting an important hot spot for small rearrangements in MYH9 exon 24.

Koji Miyazaki1, Shinji Kunishima, Wataru Fujii, Masaaki Higashihara.   

Abstract

MYH9 disorders include hereditary macrothrombocytopenias with leukocyte inclusion bodies. Among more than 200 genetically confirmed families, the vast majority of cases exhibit single point mutations including substitutions and deletions of the COOH-terminus in the protein-coding sequence of MYH9. Only four in-frame deletions have been reported to date. In the current study, we describe three in-frame deletions including p.E1084del, p.E1066_A1072del and p.G1055_Q1068del, all of which are localized to exon 24. Interestingly, these three deletions were found to induce the diverse clinical manifestations on the non-hematological symptoms, while they equally demonstrated type I staining of inclusion bodies. As a result of these findings, we suggest that exon 24 represents a potential 'hot spot' for unequal homologous recombination, which may generate in-frame deletions in the coiled-coil rod of non-muscle myosin heavy chain-IIA. The exact length and position of these deletions may also determine the severity of the non-hematological manifestations, however does not appear to affect the morphology of the leukocyte inclusion bodies. These findings further our current understanding of the molecular pathogenesis underlying MYH9 disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19459928     DOI: 10.1111/j.1600-0609.2009.01274.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  5 in total

1.  A Trp33Arg mutation at exon 1 of the MYH9 gene in a Korean patient with May-Hegglin anomaly.

Authors:  Moon Ju Jang; Hyun-Jeong Park; So Young Chong; Ji Young Huh; In-Ho Kim; Ja-Hyun Jang; Hee-Jin Kim; Doyeun Oh
Journal:  Yonsei Med J       Date:  2012-05       Impact factor: 2.759

Review 2.  MYH9: Structure, functions and role of non-muscle myosin IIA in human disease.

Authors:  Alessandro Pecci; Xuefei Ma; Anna Savoia; Robert S Adelstein
Journal:  Gene       Date:  2018-04-19       Impact factor: 3.688

Review 3.  Non-muscle myosin II takes centre stage in cell adhesion and migration.

Authors:  Miguel Vicente-Manzanares; Xuefei Ma; Robert S Adelstein; Alan Rick Horwitz
Journal:  Nat Rev Mol Cell Biol       Date:  2009-11       Impact factor: 94.444

4.  MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations.

Authors:  Daniela De Rocco; Barbara Zieger; Helen Platokouki; Paula G Heller; Annalisa Pastore; Roberta Bottega; Patrizia Noris; Serena Barozzi; Ana C Glembotsky; Helen Pergantou; Carlo L Balduini; Anna Savoia; Alessandro Pecci
Journal:  Eur J Med Genet       Date:  2012-10-30       Impact factor: 2.708

5.  Two Cases of the MYH9 Disorder Fechtner Syndrome Diagnosed from Observation of Peripheral Blood Cells before End-Stage Renal Failure.

Authors:  Shin Teshirogi; Jun Muratsu; Hidenori Kasahara; Ken Terashima; Sho Miki; Tomohiro Minami; Yujiro Okute; Suguru Yoneda; Atsuyuki Morishima; Shinji Kunishima; Katsuhiko Sakaguchi
Journal:  Case Rep Nephrol       Date:  2019-11-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.